Early studies indicate that Omicron’s spike protein mutations help the variant evade virus-fighting antibodies generated by previous infections or vaccines. Photo: Shutterstock
Vaccine T-cells may hold robust defensive line against Omicron variant: study
- Researchers in Hong Kong and Australia say T-cell responses induced by vaccines and previous infections might help protect against severe illness
- But cases might rise because of Omicron’s ability to evade antibodies
Early studies indicate that Omicron’s spike protein mutations help the variant evade virus-fighting antibodies generated by previous infections or vaccines. Photo: Shutterstock
